Methylphenidate Hydrochloride Tablet, Extended Release
FDA Label NDC 51407-925

47 label sections · Submitted to the FDA by Golden State Medical Supply, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Golden State Medical Supply, Inc. for the product Methylphenidate Hydrochloride (NDC 51407-925). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: abuse, misuse, and addiction, 1 indications and usage, 2.1 pretreatment screening, 2.2 important administration instructions, 2.3 recommended methylphenidate hydrochloride extended-release tablets dosage in patients new to methylphenidate, 2.4 recommended methylphenidate hydrochloride extended-release tablets dosage in patients switching from another methylphenidate product, 2.5 dosage reduction and discontinuation, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.